119 related articles for article (PubMed ID: 14769840)
1. Study of paclitaxel and dose escalation of cisplatin in patients with advanced non-small cell lung cancer.
Watanabe H; Yamamoto N; Tamura T; Shimoyama T; Hotta K; Inoue A; Sawada M; Akiyama Y; Kusaba H; Nokihara H; Sekine I; Kunitoh H; Ohe Y; Kodama T; Saijo N
Jpn J Clin Oncol; 2003 Dec; 33(12):626-30. PubMed ID: 14769840
[TBL] [Abstract][Full Text] [Related]
2. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
[TBL] [Abstract][Full Text] [Related]
3. A feasibility study of paclitaxel 225 mg/m(2) and carboplatin AUC = 6 in untreated advanced non-small cell lung cancer patients in Japan.
Ogawara M; Kawahara M; Hosoe S; Atagi S; Kawaguchi T; Okishio K; Naka N; Sunami T; Mitsuoka S; Inoue K; Haryu H; Yoneda T; Origasa H
Jpn J Clin Oncol; 2002 Feb; 32(2):48-53. PubMed ID: 11948228
[TBL] [Abstract][Full Text] [Related]
4. A dose escalation study of paclitaxel and carboplatin in untreated Japanese patients with advanced non-small cell lung cancer.
Akiyama Y; Ohe Y; Tamura T; Sawada M; Inoue A; Kusaba H; Yamamoto N; Sekine I; Kunitoh H; Kodama T; Saijo N
Jpn J Clin Oncol; 2001 Oct; 31(10):482-7. PubMed ID: 11696617
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of paclitaxel plus cisplatin for advanced non-small-cell lung cancer in Japanese patients.
Sakai H; Yoneda S; Tamura T; Nishiwaki Y; Yokoyama A; Watanabe K; Saijo N
Cancer Chemother Pharmacol; 2001 Dec; 48(6):499-503. PubMed ID: 11800032
[TBL] [Abstract][Full Text] [Related]
6. Phase I and pharmacological study of paclitaxel given over 3 h with cisplatin for advanced non-small cell lung cancer.
Kurata T; Tamura T; Shinkai T; Ohe Y; Kunitoh H; Kodama T; Kakinuma R; Matsumoto T; Kubota K; Omatsu H; Nishiwaki Y; Saijo N
Jpn J Clin Oncol; 2001 Mar; 31(3):93-9. PubMed ID: 11336328
[TBL] [Abstract][Full Text] [Related]
7. A phase I/II study of cisplatin and vinorelbine chemotherapy in patients with advanced non-small cell lung cancer.
Hotta K; Sekine I; Tamura T; Sawada M; Watanabe H; Kusaba H; Akiyama Y; Inoue A; Shimoyama T; Nokihara H; Ueda Y; Yamamoto N; Kunitoh H; Ohe Y; Kodama T; Saijo N
Jpn J Clin Oncol; 2001 Dec; 31(12):596-600. PubMed ID: 11902490
[TBL] [Abstract][Full Text] [Related]
8. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of weekly docetaxel combined with cisplatin in patients with non-small cell lung cancer.
Koizumi T; Tsunoda T; Fujimoto K; Nomura H; Hirai K; Koyama S; Okada K; Kubo K
Lung Cancer; 2001 Oct; 34(1):125-31. PubMed ID: 11557122
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin, paclitaxel and escalating doses of doxorubicin (TAP) in advanced ovarian cancer: a phase I trial.
Onda T; Katsumata N; Tsunematsu R; Yasugi T; Mushika M; Yamamoto K; Fujii T; Hirakawa T; Kamura T; Saito T; Yoshikawa H
Jpn J Clin Oncol; 2004 Sep; 34(9):540-6. PubMed ID: 15466828
[TBL] [Abstract][Full Text] [Related]
11. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer.
Lee KW; Im SA; Yun T; Song EK; Na Ii; Shin H; Choi IS; Oh DY; Kim JH; Kim DW; Kim TY; Lee JS; Heo DS; Bang YJ; Kim NK
Jpn J Clin Oncol; 2005 Dec; 35(12):720-6. PubMed ID: 16332718
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer.
Socinski MA; Sandler AB; Miller LL; Locker PK; Hanover CK; Elfring GL; Israel VK; Pirotta N; Natale RB
J Clin Oncol; 2001 Feb; 19(4):1078-87. PubMed ID: 11181672
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer.
Polee MB; Verweij J; Siersema PD; Tilanus HW; Splinter TA; Stoter G; Van der Gaast A
Eur J Cancer; 2002 Jul; 38(11):1495-500. PubMed ID: 12110496
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
von Pawel J; Wagner H; Niederle N; Heider A; Koschel G; Hecker D; Hanske M
Semin Oncol; 1996 Dec; 23(6 Suppl 16):47-50. PubMed ID: 9007121
[TBL] [Abstract][Full Text] [Related]
16. A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non-small cell lung cancer.
Soria JC; Adjei AA; Bahleda R; Besse B; Ferte C; Planchard D; Zhou J; Ware J; Morrissey K; Shankar G; Lin W; Schutzman JL; Dy GK; Groen HJM
Eur J Cancer; 2017 Nov; 86():186-196. PubMed ID: 28992562
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours.
Kosmas C; Tsavaris NB; Polyzos A; Malamos NA; Katsikas M; Antonopoulos MJ
Br J Cancer; 2000 Jan; 82(2):300-7. PubMed ID: 10646881
[TBL] [Abstract][Full Text] [Related]
18. Phase I/II study of 3-week cycle cisplatin-gemcitabine in advanced non-small cell lung cancer.
Kusaba H; Tamura T; Shimoyama T; Hotta K; Inoue A; Nokihara H; Ueda Y; Akiyama Y; Yamamoto N; Sekine I; Kunitoh H; Ohe Y; Kodama T; Saijo N
Jpn J Clin Oncol; 2002 Feb; 32(2):43-7. PubMed ID: 11948227
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of paclitaxel (Genaxol) and cisplatin combination in treating Chinese patients with advanced non-small cell lung cancer (NSCLC).
Chen CH; Chang WC; Lin MC; Hsu JW; Chao TY; Tsao TC
Lung Cancer; 2002 Oct; 38(1):91-6. PubMed ID: 12367799
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel administered over 3 h followed by cisplatin in patients with advanced head and neck squamous cell carcinoma: a clinical phase I study.
Schilling T; Heinrich B; Kau R; Herzog M; Quasthoff S; Diergarten K; Rastetter J; Hanauske AR
Oncology; 1997; 54(2):89-95. PubMed ID: 9075777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
